Hakim, Mohamad S <br/><br/>
Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy.  [electronic resource] 

 -  Reviews in medical virology  03 2020 
 - e2094 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1099-1654 
<br/><br/><label>Standard No.: </label>10.1002/rmv.2094  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Disease Susceptibility<br/>Gene Expression Regulation<br/>Hepacivirus--physiology<br/>Hepatitis B--drug therapy<br/>Hepatitis B virus--physiology<br/>Hepatitis B, Chronic--drug therapy<br/>Hepatitis C--drug therapy<br/>Hepatitis C, Chronic--drug therapy<br/>Host-Pathogen Interactions--genetics<br/>Humans<br/>Immune Checkpoint Proteins--genetics<br/>Molecular Targeted Therapy<br/>T-Lymphocyte Subsets--drug effects